In today’s recent session, 0.56 million shares of the GlycoMimetics Inc (NASDAQ:GLYC) have been traded, and its beta is 2.06. Most recently the company’s share price was $0.17, and it changed around $0.0 or 0.00% from the last close, which brings the market valuation of the company to $10.64M. GLYC at last check was trading at a discount to its 52-week high of $3.53, offering almost -1976.47% off that amount. The share price’s 52-week low was $0.16, which indicates that the recent value has risen by an impressive 5.88% since then. We note from GlycoMimetics Inc’s average daily trading volume that its 10-day average is 0.43 million shares, with the 3-month average coming to 3.74 million.
GlycoMimetics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended GLYC as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. GlycoMimetics Inc is expected to report earnings per share of -0.13 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GlycoMimetics Inc (NASDAQ:GLYC) trade information
The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.1830 on recent trading dayincreased the stock’s daily price by 7.1%. The company’s shares are currently down -93.01% year-to-date, but still up 1.60% over the last five days. On the other hand, GlycoMimetics Inc (NASDAQ:GLYC) is -3.06% down in the 30-day period. We can see from the shorts that 1.93 million shares have been sold at a short interest cover period of 1.27 day(s).
GlycoMimetics Inc (GLYC) estimates and forecasts
GlycoMimetics Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -94.37 percent over the past six months and at a 3.45% annual growth rate that is well below the industry average of 20.00%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 7.10% in revenue this quarter, and will report an increase of 21.40% in the next quarter.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 13.11%.
GLYC Dividends
GlycoMimetics Inc’s next quarterly earnings report is expected to be released on 2024-Nov-01.
GlycoMimetics Inc (NASDAQ:GLYC)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 8.86% of GlycoMimetics Inc shares, and 34.98% of them are in the hands of institutional investors. The stock currently has a share float of 38.38%. GlycoMimetics Inc stock is held by 47.0 institutions, with BVF INC/IL being the largest institutional investor. By 2024-06-30, it held 14.8071% of the shares, which is about 9.54 million shares worth $2.69 million.
ARTAL GROUP S.A., with 13.3252% or 8.59 million shares worth $2.42 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Jun 30, 2024. The former held 1.93 shares worth $0.31 million, making up 2.99% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 730.6 shares worth around $0.12 million, which represents about 1.13% of the total shares outstanding.
